Tag Archives: Ambry

Athena v. Mayo Part II – Iancu v. The Federal Circuit(?)

The 2019 Revised Subject Matter Eligibility Guidance published on January 7th purported to revise the procedures for determining whether a patent claim or patent application claim is “directed to a judicial exception (laws of nature, natural phenomena, and abstract ideas) … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , , , , , , , , | Leave a comment

The “Top Ten” IP Stories of 2014 (Most “Definitely”)

I don’t think I can recall a more action-packed year for intellectual property law in my career, much less during the almost six years that I have been writing this blog. I am trying to write this while in transit, … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Myriad Brings Out Its “Reserve Claims” To Challenge Ambry

In my post on this blog of June 17th, I speculated that the positive comments by the Supreme Court in the Myriad decision about the patent-eligibility of claims directed to new applications of natural products (like the BRCA genes) would … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , | Leave a comment